Sudeep Pharma
Mainboard₹14,825 / 25 Shares
IPO Live Subscription Details (times)
IPO Details
Sudeep Pharma IPO is priced between ₹563-593 per equity share, with a face value of ₹1 per share. The company's equity shares will be listed on the Mainboard, and MUFG Intime India Pvt Ltd is managing the issue as the registrar.
The IPO bidding period opened on 21 Nov, 2025, and closed on 25 Nov, 2025. The allotment results will be announced on 26 Nov, 2025, with a tentative listing date set for 28 Nov, 2025.
The total issue comprises 1,50,92,750 shares, amounting to ₹895 crore.
Sudeep Pharma IPO Highlights
| IPO Date | Listing Date | Face Value | Price Band | Lot Size | Fresh Issue | Offer for Sale | Listing At |
|---|---|---|---|---|---|---|---|
| Nov 21, 2025 - Nov 25, 2025 | 28 Nov, 2025 | ₹1 Per Equity Share | ₹563-593 per equity share | 25 Shares | Shares | - | BSE, NSE |
Sudeep Pharma IPO Timeline
Issue Price
₹563-593 per equity shareFace Value
₹1 Per Equity ShareListing at Group
BSE, NSERegistrar
MUFG Intime India Pvt LtdMarket Lot
Retail: 25 Shares (₹14,825/-)Retail: 325 Shares (₹1,92,725/-)S-HNI: 350 Shares (₹2,07,550/-)
S-HNI: 1,675 Shares (₹9,93,275/-)
B-HNI: 1,700 Shares (₹10,08,100/-)
Lead Manager
ICICI Securities Ltd.IIFL Capital Services Ltd.Issue Size
1,50,92,750 shares(aggregating up to ₹895 crore)Retail Portion
Subscription
IPO Docs
No IPO Docs availableSudeep Pharma IPO Documents
Sudeep Pharma IPO Valuations
EPS PRE IPO ₹12.46/- | EPS POST IPO ₹11.07/- | PE PRE IPO 47.61 | PE POST IPO 53.55 | ROE - |
ROCE - | DEBT EQUITY 0.20 | RONW 27.88% | PAT MARGIN 27.63% | PRICE TO BOOK VALUE 12.93 |
About Company
Incorporated in 1989, Sudeep Pharma Limited is a manufacturer of pharmaceutical excipients, food-grade minerals, and specialty nutrition ingredients serving over 100 countries.It has six manufacturing facilities that have a combined production capacity of 50,000 MT, manufacturing minerals such as calcium, iron, magnesium, zinc, potassium, and sodium.
The company supplies over 200 products to a wide customer base across the pharma, food, and nutrition sectors.The company has strong R&D capabilities comprising in-house labs and pilot-scale facilities for mineral salts and excipients.
Product Portfolio:
Pharmaceutical, Food and Nutrition Business
Specialty Ingredients Business
Triturates As of 31 December 2024, the company had 704 permanent employees.
Sudeep Pharma IPO Subscription Details
| As on | QIB | NII bNII sNII | Retail | Total |
|---|---|---|---|---|
| Shares Offered / Reserved | 30,18,553 | 22,63,912 15,09,275 7,54,637 | 52,82,462 | 1,05,64,927 |
| Day 121-11-25 05:00 PM | 0.09 x | 3.00 2.75 x 3.51 x | 1.51 x | 1.42 x |
| Day 224-11-25 05:00 PM | 0.13 x | 12.01 10.99 x 14.04 x | 4.99 x | 5.11 x |
| Day 325-11-25 05:00 PM | 213.08 x | 116.72 134.91 x 80.33 x | 15.65 x | 93.71 x |
Retail:12.88x
BHNI:27.29x
SHNI:76.34x
Sudeep Pharma IPO - Issue Objectives
- Capital expenditure towards procurement of machinery for the production line located at Nandesari Facility I– ₹75.81 Cr
- General corporate purposes
Sudeep Pharma
129/1/A, GIDC Estate, Nandesari, Vadodara, Gujarat, 391340MUFG Intime India Private Limited (Link Intime)
Phone: +91-22-4918 6270
Email: sudeeppharma.ipo@in.mpms.mufg.com
Website: https://in.mpms.mufg.com/Initial_Offer/public-issues.html